List of works - Hwai-I Yang

A Glycomarker for Short-term Prediction of Hepatocellular Carcinoma: A Longitudinal Study With Serial Measurements

A predictive scoring system for the seroclearance of HBsAg in HBeAg-seronegative chronic hepatitis B patients with genotype B or C infection

scientific article published on 13 December 2012

Aflatoxin B1 exposure increases the risk of hepatocellular carcinoma associated with hepatitis C virus infection or alcohol consumption.

scientific article published on 10 March 2018

Aflatoxin B1 exposure, hepatitis B virus infection, and hepatocellular carcinoma in Taiwan

scientific article

Alcohol Drinking Mediates the Association between Polymorphisms of ADH1B and ALDH2 and Hepatitis B-Related Hepatocellular Carcinoma.

scientific article

Association Between High Levels of Hepatitis B Core Antibody and Seroclearance of Hepatitis B e Antigen in Individuals With Chronic Hepatitis B Virus Infection

scientific article published on 26 September 2018

Association between Traffic Count and Cardiovascular Mortality: A Prospective Cohort Study in Taiwan

scientific article published on 20 June 2020

Author's response: Hepatitis B virus seromarkers clearance and risk of hepatocellular carcinoma: serious risks of misinterpretation

scientific article published on 4 February 2014

Blood DNA methylation markers in prospectively identified hepatocellular carcinoma cases and controls from Taiwan

scientific article published on February 2016

Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma

scientific article published on 22 June 2011

Characteristics of Patients With Chronic Hepatitis B Virus Infection With Genotype E Predominance in Burkina Faso

scientific article published on 15 September 2020

Chronic hepatitis B infection and risk of atherosclerosis-related mortality: A 17-year follow-up study based on 22,472 residents in Taiwan

scientific article published on 10 March 2010

Chronic hepatitis C virus infection and the risk for diabetes: a community-based prospective study

scientific article published on July 2016

Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study

scientific article published on 17 July 2012

Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients.

scientific article

Community and personal risk factors for hepatitis C virus infection: a survey of 23,820 residents in Taiwan in 1991-2.

scientific article published on 10 November 2010

Development and validation of a clinical scoring system for predicting risk of HCC in asymptomatic individuals seropositive for anti-HCV antibodies

scientific article

Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium

scientific article published on 28 August 2019

Distinct seromarkers predict different milestones of chronic hepatitis B progression.

scientific article published on 28 May 2014

Epidemiology and natural history of hepatitis C virus infection

scientific article

Epidemiology of Virus Infection and Human Cancer

scientific article published on 01 January 2021

Epidemiology of virus infection and human cancer

scientific article published on January 2014

Estimating the Incidence and Prevalence of Chronic Hepatitis C Infection in Taiwan Using Back Projection

scientific article published on 30 October 2013

Evaluation for the Genetic Association between Store-Operated Calcium Influx Pathway (STIM1 and ORAI1) and Human Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection

scientific article published on 09 November 2020

Fifteen-year population attributable fractions and causal pies of risk factors for newly developed hepatocellular carcinomas in 11,801 men in Taiwan

scientific article

Fine Particle Pollution, Alanine Transaminase, and Liver Cancer: A Taiwanese Prospective Cohort Study (REVEAL-HBV).

scientific article published on March 2015

Global DNA methylation in a population with aflatoxin B1 exposure

scientific article published on 18 July 2013

Global DNA methylation levels in white blood cells as a biomarker for hepatocellular carcinoma risk: a nested case-control study

scientific article

HCV Cure Rates are Reduced in Patients with Active but not Inactive Hepatocellular Carcinoma- A Practice Implication

scientific article published on 28 November 2019

Hepatitis B e antigen and the risk of hepatocellular carcinoma

scientific article

Hepatitis B virus DNA levels and outcomes in chronic hepatitis B.

scientific article published on May 2009

Hepatitis C viral load, genotype, and increased risk of developing end-stage renal disease: REVEAL-HCV study

scientific article

Hepatitis C virus genotype 1b increases cumulative lifetime risk of hepatocellular carcinoma.

scientific article published on 14 February 2014

Hepatitis C virus infection and increased risk of cerebrovascular disease.

scientific article published on 21 October 2010

Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study

scientific article published on 20 September 2010

Hepatocellular carcinoma risk scores: ready to use in 2015?

scientific article published on 12 January 2015

High hepatitis C viral load and genotype 2 are strong predictors of chronic kidney disease

scientific article published on 20 May 2017

Host genetic factors affecting spontaneous HBsAg seroclearance in chronic hepatitis B patients

scientific article

Human Leukocyte Antigen Variants and Risk of Hepatocellular Carcinoma Modified by HCV Genotypes: A Genome-wide Association Study

scientific article published on 16 September 2017

Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study

scientific article published on 29 April 2010

Incidence and determinants of spontaneous seroclearance of hepatitis B e antigen and DNA in patients with chronic hepatitis B.

scientific article published on 16 December 2011

Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis.

scientific article published on 17 November 2015

Level of Hepatitis B (HB) Core Antibody Associates With Seroclearance of HBV DNA and HB Surface Antigen in HB e Antigen-Seronegative Patients

scientific article published on 09 May 2018

Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C

scientific article published on 22 August 2011

Lifetime risk of distinct upper aerodigestive tract cancers and consumption of alcohol, betel and cigarette

scientific article published on 03 March 2014

Long-term outcomes in hepatitis B: the REVEAL-HBV study

scientific article published on November 2007

Lower liver cancer risk with antiviral therapy in chronic hepatitis B patients with normal to minimally elevated ALT and no cirrhosis

scientific article published on August 2016

Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan.

scientific article published on 4 April 2008

Natural history of chronic hepatitis B REVEALed

scientific article published on April 2011

Natural history of chronic hepatitis B: what exactly has REVEAL revealed?

scientific article published on 17 April 2012

Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection

scientific article published on 5 April 2010

Obesity and alcohol synergize to increase the risk of incident hepatocellular carcinoma in men.

scientific article published on 17 August 2010

Patterns of Human Leukocyte Antigen Class I and Class II Associations and Cancer

scientific article published on 03 December 2020

Performance Metrics for Selecting Single Nucleotide Polymorphisms in Late-onset Alzheimer's Disease.

scientific article

Plasma DNA methylation marker and hepatocellular carcinoma risk prediction model for the general population

scientific article published on 3 August 2017

Plasma adipokines and risk of hepatocellular carcinoma in chronic hepatitis B virus-infected carriers: a prospective study in taiwan

scientific article published on 3 June 2014

Polycyclic aromatic hydrocarbon- and aflatoxin-albumin adducts, hepatitis B virus infection and hepatocellular carcinoma in Taiwan

scientific article

Polymorphisms near the IFNL3 Gene Associated with HCV RNA Spontaneous Clearance and Hepatocellular Carcinoma Risk

scientific article

Predictability of liver-related seromarkers for the risk of hepatocellular carcinoma in chronic hepatitis B patients.

scientific article

Predicting Hepatitis B Virus (HBV) Surface Antigen Seroclearance in HBV e Antigen-Negative Patients With Chronic Hepatitis B: External Validation of a Scoring System

scientific article published on 27 November 2014

Predicting hepatocellular carcinoma by detection of aberrant promoter methylation in serum DNA

scientific article published on 01 April 2007

Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.

scientific article published in August 2013

R331W Missense Mutation of Oncogene YAP1 Is a Germline Risk Allele for Lung Adenocarcinoma With Medical Actionability

scientific article published on 8 June 2015

Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis.

scientific article

Risk and predictors of mortality associated with chronic hepatitis B infection

scientific article published on 01 August 2007

Risk calculators for hepatocellular carcinoma in patients affected with chronic hepatitis B in Asia

scientific article

Risk of hepatitis C virus related hepatocellular carcinoma between subjects with spontaneous and treatment-induced viral clearance

scientific article published on February 2017

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

scientific article

Risk of pancreatic cancer in chronic hepatitis B virus infection: data from the REVEAL-HBV cohort study

scientific article

Seropositivity of hepatitis B e antigen and hepatocellular carcinoma

scientific article published on January 2004

Serum Levels of Hepatitis B Surface Antigen and DNA Can Predict Inactive Carriers With Low Risk of Disease Progression.

scientific article published on 15 April 2016

Serum Levels of M2BPGi as Short-Term Predictors of Hepatocellular Carcinoma in Untreated Chronic Hepatitis B Patients

scientific article published on 30 October 2017

Significant reduction in end-stage liver diseases burden through the national viral hepatitis therapy program in Taiwan.

scientific article published on 10 February 2015

Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma

scientific article published on 13 November 2013

Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study

scientific article published on 24 January 2013

Synergistic effects of family history of hepatocellular carcinoma and hepatitis B virus infection on risk for incident hepatocellular carcinoma.

scientific article

Telomere Length and Risk of Hepatocellular Carcinoma: A Nested Case-control Study in Taiwan Cancer Screening Program Cohort

scientific article published on February 2017

Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B

scientific article published on 01 February 2020

The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B.

scientific article

Urinary 15-F2t-isoprostane, aflatoxin B1 exposure and hepatitis B virus infection and hepatocellular carcinoma in Taiwan

scientific article

Urinary 8-oxodeoxyguanosine, aflatoxin B1 exposure and hepatitis B virus infection and hepatocellular carcinoma in Taiwan

scientific article published on 24 November 2006

List of works by Hwai-I Yang

A Glycomarker for Short-term Prediction of Hepatocellular Carcinoma: A Longitudinal Study With Serial Measurements

A predictive scoring system for the seroclearance of HBsAg in HBeAg-seronegative chronic hepatitis B patients with genotype B or C infection

Aflatoxin B1 exposure increases the risk of hepatocellular carcinoma associated with hepatitis C virus infection or alcohol consumption.

Aflatoxin B1 exposure, hepatitis B virus infection, and hepatocellular carcinoma in Taiwan

Alcohol Drinking Mediates the Association between Polymorphisms of ADH1B and ALDH2 and Hepatitis B-Related Hepatocellular Carcinoma.

Association Between High Levels of Hepatitis B Core Antibody and Seroclearance of Hepatitis B e Antigen in Individuals With Chronic Hepatitis B Virus Infection

Association between Traffic Count and Cardiovascular Mortality: A Prospective Cohort Study in Taiwan

Author's response: Hepatitis B virus seromarkers clearance and risk of hepatocellular carcinoma: serious risks of misinterpretation

Blood DNA methylation markers in prospectively identified hepatocellular carcinoma cases and controls from Taiwan

Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma

Characteristics of Patients With Chronic Hepatitis B Virus Infection With Genotype E Predominance in Burkina Faso

Chronic hepatitis B infection and risk of atherosclerosis-related mortality: A 17-year follow-up study based on 22,472 residents in Taiwan

Chronic hepatitis C virus infection and the risk for diabetes: a community-based prospective study

Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study

Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients.

Community and personal risk factors for hepatitis C virus infection: a survey of 23,820 residents in Taiwan in 1991-2.

Development and validation of a clinical scoring system for predicting risk of HCC in asymptomatic individuals seropositive for anti-HCV antibodies

Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium

Distinct seromarkers predict different milestones of chronic hepatitis B progression.

Epidemiology and natural history of hepatitis C virus infection

Epidemiology of Virus Infection and Human Cancer

Epidemiology of virus infection and human cancer

Estimating the Incidence and Prevalence of Chronic Hepatitis C Infection in Taiwan Using Back Projection

Evaluation for the Genetic Association between Store-Operated Calcium Influx Pathway (STIM1 and ORAI1) and Human Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection

Fifteen-year population attributable fractions and causal pies of risk factors for newly developed hepatocellular carcinomas in 11,801 men in Taiwan

Fine Particle Pollution, Alanine Transaminase, and Liver Cancer: A Taiwanese Prospective Cohort Study (REVEAL-HBV).

Global DNA methylation in a population with aflatoxin B1 exposure

Global DNA methylation levels in white blood cells as a biomarker for hepatocellular carcinoma risk: a nested case-control study

HCV Cure Rates are Reduced in Patients with Active but not Inactive Hepatocellular Carcinoma- A Practice Implication

Hepatitis B e antigen and the risk of hepatocellular carcinoma

Hepatitis B virus DNA levels and outcomes in chronic hepatitis B.

Hepatitis C viral load, genotype, and increased risk of developing end-stage renal disease: REVEAL-HCV study

Hepatitis C virus genotype 1b increases cumulative lifetime risk of hepatocellular carcinoma.

Hepatitis C virus infection and increased risk of cerebrovascular disease.

Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study

Hepatocellular carcinoma risk scores: ready to use in 2015?

High hepatitis C viral load and genotype 2 are strong predictors of chronic kidney disease

Host genetic factors affecting spontaneous HBsAg seroclearance in chronic hepatitis B patients

Human Leukocyte Antigen Variants and Risk of Hepatocellular Carcinoma Modified by HCV Genotypes: A Genome-wide Association Study

Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study

Incidence and determinants of spontaneous seroclearance of hepatitis B e antigen and DNA in patients with chronic hepatitis B.

Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis.

Level of Hepatitis B (HB) Core Antibody Associates With Seroclearance of HBV DNA and HB Surface Antigen in HB e Antigen-Seronegative Patients

Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C

Lifetime risk of distinct upper aerodigestive tract cancers and consumption of alcohol, betel and cigarette

Long-term outcomes in hepatitis B: the REVEAL-HBV study

Lower liver cancer risk with antiviral therapy in chronic hepatitis B patients with normal to minimally elevated ALT and no cirrhosis

Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan.

Natural history of chronic hepatitis B REVEALed

Natural history of chronic hepatitis B: what exactly has REVEAL revealed?

Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection

Obesity and alcohol synergize to increase the risk of incident hepatocellular carcinoma in men.

Patterns of Human Leukocyte Antigen Class I and Class II Associations and Cancer

Performance Metrics for Selecting Single Nucleotide Polymorphisms in Late-onset Alzheimer's Disease.

Plasma DNA methylation marker and hepatocellular carcinoma risk prediction model for the general population

Plasma adipokines and risk of hepatocellular carcinoma in chronic hepatitis B virus-infected carriers: a prospective study in taiwan

Polycyclic aromatic hydrocarbon- and aflatoxin-albumin adducts, hepatitis B virus infection and hepatocellular carcinoma in Taiwan

Polymorphisms near the IFNL3 Gene Associated with HCV RNA Spontaneous Clearance and Hepatocellular Carcinoma Risk

Predictability of liver-related seromarkers for the risk of hepatocellular carcinoma in chronic hepatitis B patients.

Predicting Hepatitis B Virus (HBV) Surface Antigen Seroclearance in HBV e Antigen-Negative Patients With Chronic Hepatitis B: External Validation of a Scoring System

Predicting hepatocellular carcinoma by detection of aberrant promoter methylation in serum DNA

Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.

R331W Missense Mutation of Oncogene YAP1 Is a Germline Risk Allele for Lung Adenocarcinoma With Medical Actionability

Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis.

Risk and predictors of mortality associated with chronic hepatitis B infection

Risk calculators for hepatocellular carcinoma in patients affected with chronic hepatitis B in Asia

Risk of hepatitis C virus related hepatocellular carcinoma between subjects with spontaneous and treatment-induced viral clearance

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

Risk of pancreatic cancer in chronic hepatitis B virus infection: data from the REVEAL-HBV cohort study

Seropositivity of hepatitis B e antigen and hepatocellular carcinoma

Serum Levels of Hepatitis B Surface Antigen and DNA Can Predict Inactive Carriers With Low Risk of Disease Progression.

Serum Levels of M2BPGi as Short-Term Predictors of Hepatocellular Carcinoma in Untreated Chronic Hepatitis B Patients

Significant reduction in end-stage liver diseases burden through the national viral hepatitis therapy program in Taiwan.

Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma

Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study

Synergistic effects of family history of hepatocellular carcinoma and hepatitis B virus infection on risk for incident hepatocellular carcinoma.

Telomere Length and Risk of Hepatocellular Carcinoma: A Nested Case-control Study in Taiwan Cancer Screening Program Cohort

Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B

The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B.